ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 14 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $165,000 | – | 26,573 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 366,401 | $2,374,000 | 2.07% |
| Private Portfolio Partners LLC | 67,400 | $436,752 | 0.12% |
| Knoll Capital Management, LLC | 20,000 | $130,000 | 0.08% |
| ETF MANAGERS GROUP, LLC | 94,493 | $612,000 | 0.02% |
| Virtu Financial LLC | 21,526 | $139,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 21,904 | $142,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $36,000 | 0.01% |
| Walleye Capital LLC | 78,418 | $508,000 | 0.01% |
| Jump Financial, LLC | 36,100 | $234,000 | 0.01% |
| Plante Moran Financial Advisors, LLC | 7,911 | $51,000 | 0.01% |